Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 4/20 | 0.92 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.59 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.58 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.58 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.56 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1513545 | 0.96 | ESR2 (1.00) | ESR2ALOX5HSD17B1HSD17B2ACMSD | |
| SCHEMBL16581366 | 0.94 | ESR2 (0.79) | ESR2ALOX5HSD17B1HSD17B2ACMSD | |
| SCHEMBL28202577 | 0.84 | ESR2 (0.77) | ESR2ALOX5HSD17B1HSD17B2APP | |
| SCHEMBL278316 | 0.84 | ESR2 (0.77) | ESR2ALOX5HSD17B1HSD17B2APP | |
| SCHEMBL29911026 | 0.84 | ESR2 (0.77) | ESR2ALOX5HSD17B1HSD17B2APP | |
| SCHEMBL6854117 | 0.83 | ALOX5 (0.74) | ESR2ALOX5HSD17B1HSD17B2APP | |
| Methane SCHEMBL10594573 | 0.82 | ESR2 (0.74) | ESR2ALOX5HSD17B1HSD17B2APP | |
| SCHEMBL22379962 | 0.81 | ESR2 (0.60) | ESR2HSD17B1HSD17B2ACMSDAPP | |
| SCHEMBL11608660 | 0.80 | ESR2 (0.72) | ESR2ALOX5HSD17B1HSD17B2MEN1 | |
| SCHEMBL3566128 | 0.80 | ESR2 (0.72) | ESR2ALOX5HSD17B1HSD17B2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| US-11038126-B2 | Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-06-15 | — | — | US | disclosed |
| US-20200274078-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | RB1, ARL1, CDKL1 | ESR2 769/4885ALOX5 2987/4885HSD17B1 1786/4885 |
| US-11038126-B2 | Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device | ACVRL1, CCNL2, CXCR1 | ESR2 248/4885ALOX5 1863/4885HSD17B1 3151/4885 |
| US-20200274078-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | ACVRL1, CCNL2, CXCR1 | ESR2 248/4885ALOX5 1863/4885HSD17B1 3151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.